CD274 and melanoma: In addition, they demonstrated that the oral administration of Bifidobacterium spp., combined with anti-PD-L1 antibodies, specifically boosts T cell responses with augmented dendritic cell function, leading to enhanced CD8+ T cell priming and accumulation in the tumour microenvironment, inhibiting melanoma growth [57].